Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Oncogene ; 36(47): 6649-6657, 2017 11 23.
Article in English | MEDLINE | ID: mdl-28783172

ABSTRACT

The protein p38 mitogen-activated protein kinase (MAPK) delta isoform (p38δ) is a poorly studied member of the MAPK family. Data analysis from The Cancer Genome Atlas database revealed that p38δ is highly expressed in all types of human breast cancers. Using a human breast cancer tissue array, we confirmed elevation in cancer tissue. The breast cancer mouse model, MMTV-PyMT (PyMT), developed breast tumors with lung metastasis; however, mice deleted in p38δ (PyMT/p38δ-/-) exhibited delayed primary tumor formation and highly reduced lung metastatic burden. At the cellular level, we demonstrate that targeting of p38δ in breast cancer cells, MCF-7 and MDA-MB-231 resulted in a reduced rate of cell proliferation. In addition, cells lacking p38δ also displayed an increased cell-matrix adhesion and reduced cell detachment. This effect on cell adhesion was molecularly supported by the regulation of the focal adhesion kinase by p38δ in the human breast cell lines. These studies define a previously unappreciated role for p38δ in breast cancer development and evolution by regulating tumor growth and altering metastatic properties. This study proposes MAPK p38δ protein as a key factor in breast cancer. Lack of p38δ resulted in reduced primary tumor size and blocked the metastatic potential to the lungs.


Subject(s)
Breast Neoplasms/pathology , Cell Adhesion , Cell Proliferation , Lung Neoplasms/secondary , Mammary Neoplasms, Experimental/pathology , Mitogen-Activated Protein Kinase 13/metabolism , Animals , Breast/pathology , Disease Progression , Female , Humans , MCF-7 Cells , Mammary Neoplasms, Experimental/genetics , Mice , Mice, Transgenic , Mitogen-Activated Protein Kinase 13/genetics , Protein Isoforms/genetics , Protein Isoforms/metabolism , Tissue Array Analysis
2.
Diabetes Obes Metab ; 16 Suppl 1: 49-55, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25200296

ABSTRACT

Fatty acid (FA)-sensitive neurons are present in the brain, especially the hypothalamus, and play a key role in the neural control of energy homeostasis. Through neuronal output, FA may modulate feeding behaviour as well as insulin secretion and action. Subpopulations of neurons in the ventromedial and arcuate hypothalamic nuclei are selectively either inhibited or activated by FA. Molecular effectors of these FA effects probably include chloride or potassium ion channels. While intracellular metabolism and activation of the ATP-sensitive K⁺ channel appear to be necessary for some of the signalling effects of FA, at least half of the FA responses in ventromedial hypothalamic neurons are mediated by interaction with FAT/CD36, an FA transporter/receptor that does not require intracellular metabolism to activate downstream signalling. Thus, FA or their metabolites can modulate neuronal activity as a means of directly monitoring ongoing fuel availability by brain nutrient-sensing neurons involved in the regulation of energy and glucose homeostasis. Recently, the role of lipoprotein lipase in FA sensing has also been shown in animal models not only in hypothalamus, but also in hippocampus and striatum. Finally, FA overload might impair neural control of energy homeostasis through enhanced ceramide synthesis and may contribute to obesity and/or type 2 diabetes pathogenesis in predisposed subjects.


Subject(s)
CD36 Antigens/metabolism , Fatty Acids, Nonesterified/metabolism , Feedback, Physiological , Lipid Metabolism , Models, Neurological , Neurons/metabolism , Ventromedial Hypothalamic Nucleus/metabolism , Animals , Appetite Regulation , Corpus Striatum/cytology , Corpus Striatum/metabolism , Fatty Acids, Nonesterified/blood , Hippocampus/cytology , Hippocampus/metabolism , Humans , Lipoprotein Lipase/metabolism , Nerve Tissue Proteins/metabolism , Neurons/cytology , Organ Specificity , Ventromedial Hypothalamic Nucleus/cytology
3.
Cell Death Differ ; 17(9): 1474-85, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20224597

ABSTRACT

Ischemia/reperfusion injury (IRI) causes inflammation and cell injury as a result of activating innate immune signaling. Toll-like receptor 4 (TLR4) has a key role in mediating kidney damages during IRI, but the downstream signaling pathway(s) stimulating apoptosis remains debated. In this study we show that TLR4 mediates MyD88-dependent activation of TNF receptor-associated factor 2, apoptosis signal-regulating kinase 1 (ASK1), and Jun N-terminal kinase (JNK) and p38 MAP kinases in ischemic-reperfused kidneys and posthypoxic renal tubule epithelial cells (RTECs). Hypoxia stimulated the expression of the endoplasmic-resident gp96, which co-immunoprecipitated TLR4, whereas silencing gp96 mRNA expression impaired hypoxia-induced apoptosis in TLR4-expressing RTECs. NAD(P)H oxidase 4 (NOX4) was shown to interact with TLR4 and to be required in lipopolysaccharide-induced production of reactive oxygen species (ROS). IRI stimulated the expression of a 28-kDa NOX4 spliced isoform abundantly expressed in wild-type RTECs, which co-immunoprecipitated with TLR4, but not with gp96 in TLR4-deficient RTECs. Silencing NOX4 mRNA expression impaired hypoxia-induced activation of ASK1 and both JNK and p38, leading to the inhibition of ROS production and apoptosis in posthypoxic TLR4-expressing RTECs. These findings show that, concomitantly to the activation of p38, the gp96/TLR4 interaction is required for activation of ASK1/JNK signaling in posthypoxic mouse RTECs, and that the 28-kDa NOX4 has a key role in TLR4-mediated apoptosis during renal IRI.


Subject(s)
Apoptosis/physiology , Kidney/metabolism , Membrane Glycoproteins/metabolism , NADPH Oxidases/metabolism , Reperfusion Injury/metabolism , Toll-Like Receptor 4/metabolism , Animals , Apoptosis/drug effects , Cell Hypoxia/physiology , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Female , Isoenzymes/metabolism , JNK Mitogen-Activated Protein Kinases/antagonists & inhibitors , JNK Mitogen-Activated Protein Kinases/metabolism , Kidney/cytology , Kidney Tubules/cytology , Kidney Tubules/metabolism , MAP Kinase Kinase Kinase 5/metabolism , Membrane Glycoproteins/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Myeloid Differentiation Factor 88/genetics , Myeloid Differentiation Factor 88/metabolism , NADPH Oxidase 4 , NADPH Oxidases/genetics , Protein Binding/physiology , Protein Kinase Inhibitors/pharmacology , RNA, Small Interfering/genetics , Reactive Oxygen Species/metabolism , Reperfusion Injury/genetics , Signal Transduction/drug effects , Signal Transduction/physiology , TNF Receptor-Associated Factor 2/genetics , TNF Receptor-Associated Factor 2/metabolism , Toll-Like Receptor 4/genetics , bcl-2-Associated X Protein/metabolism , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , p38 Mitogen-Activated Protein Kinases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...